Manager × security

Laurion Capital Management LP BBIO holdings history

Who else holds this security? →

BRIDGEBIO PHARMA INC · CUSIP 10806X102 · CIK 1390202

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Laurion Capital Management LP reported 1.35M BBIO (shares), valued at $100.71M, or 7.30% of its reported non-derivative portfolio. Filed 2026-08-13.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
7.30%
Shares
1.35M
1,352,234
Reported value
$100.71M
USD

Shares increased 7.09%; reported value increased 7.41%, and weight changed -1.50 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20267.30%1,352,234SEC filing ↗Filed Aug 13, 2026
Q1 20268.80%1,262,651SEC filing ↗Filed May 14, 2026
Q4 20257.32%1,402,150SEC filing ↗Filed Feb 17, 2026Amended
Q3 202512.42%1,753,544SEC filing ↗Filed Nov 17, 2025
Q2 202512.02%2,411,248SEC filing ↗Filed Aug 14, 2025
Q1 20257.92%2,978,167SEC filing ↗Filed May 15, 2025
Q4 20246.39%3,740,896SEC filing ↗Filed Feb 14, 2025
Q3 20246.36%3,894,282SEC filing ↗Filed Nov 14, 2024
Q2 20243.62%4,388,873SEC filing ↗Filed Aug 14, 2024
Q1 20244.45%5,176,328SEC filing ↗Filed May 15, 2024
Q4 20237.59%5,241,833SEC filing ↗Filed Feb 14, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20237.59%5,241,833$211.61MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 14, 2024
Q1 20244.45%5,176,328$160.05MShares decreased 1.25%; reported value decreased 24.37%, and weight changed -3.14 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20243.62%4,388,873$111.17MShares decreased 15.21%; reported value decreased 30.54%, and weight changed -0.83 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20246.36%3,894,282$99.15MShares decreased 11.27%; reported value decreased 10.81%, and weight changed +2.74 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20246.39%3,740,896$102.65MShares decreased 3.94%; reported value increased 3.53%, and weight changed +0.03 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20257.92%2,978,167$102.96MShares decreased 20.39%; reported value increased 0.30%, and weight changed +1.53 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 202512.02%2,411,248$104.12MShares decreased 19.04%; reported value increased 1.13%, and weight changed +4.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 202512.42%1,753,544$91.08MShares decreased 27.28%; reported value decreased 12.52%, and weight changed +0.40 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 17, 2025
Q4 20257.32%1,402,150$107.25MShares decreased 20.04%; reported value increased 17.76%, and weight changed -5.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20268.80%1,262,651$93.76MShares decreased 9.95%; reported value decreased 12.57%, and weight changed +1.48 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2026
Q2 20267.30%1,352,234$100.71MShares increased 7.09%; reported value increased 7.41%, and weight changed -1.50 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2026
Laurion Capital Management LP · BRIDGEBIO PHARMA INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1390202","quarter":"2026Q2","cusip":"10806X102"}

get_institutional_manager_history
{"cik":"1390202","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.